Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 3
1968 6
1969 5
1970 1
1971 2
1972 3
1973 3
1974 1
1975 3
1984 2
1986 2
1987 1
2002 1
2014 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Results by year

Filters applied: . Clear all
Page 1
Phosphatidylcholine (18:0/20:4), a potential biomarker to predict ethionamide-induced hepatic steatosis in rats.
Muta K, Saito K, Kemmochi Y, Masuyama T, Kobayashi A, Saito Y, Sugai S. Muta K, et al. J Appl Toxicol. 2022 Sep;42(9):1533-1547. doi: 10.1002/jat.4324. Epub 2022 Mar 29. J Appl Toxicol. 2022. PMID: 35315511 Free PMC article.
Ethionamide (ETH), a second-line drug for multidrug-resistant tuberculosis, is known to cause hepatic steatosis in rats and humans. To investigate predictive biomarkers for ETH-induced steatosis, we performed lipidomics analysis using plasma and liver samples …
Ethionamide (ETH), a second-line drug for multidrug-resistant tuberculosis, is known to cause hepatic steatosis in rats and humans. T …
Profile of adverse drug reactions in drug resistant tuberculosis from Punjab.
Bhushan B, Chander R, Kajal NC, Ranga V, Gupta A, Bharti H. Bhushan B, et al. Indian J Tuberc. 2014 Oct;61(4):318-24. Indian J Tuberc. 2014. PMID: 25675695
OBJECTIVE: The aim of the study was to elucidate the profile of adverse drug reactions (ADRs) associated with second-line anti-tubercular treatment for drug-resistant tuberculosis. MATERIAL AND METHODS: ADR profile of diagnosed drug-resistant tuberculosis cas …
OBJECTIVE: The aim of the study was to elucidate the profile of adverse drug reactions (ADRs) associated with second-line anti-tuberc …
Hepatic complications of antituberculous therapy.
Rossouw JE, Saunders SJ. Rossouw JE, et al. Q J Med. 1975 Jan;44(173):1-16. Q J Med. 1975. PMID: 50605
Drug hepatitis occurred in 0-32 per cent of 7492 patients receiving antituberculous therapy, while the overall incidence of drug reactions was estimated at 9 per cent. PAS was the most common cause of drug hepatitis among the 38 patients analysed. The clinica …
Drug hepatitis occurred in 0-32 per cent of 7492 patients receiving antituberculous therapy, while the overall incidence of drug …
Hepatic toxicity during chemotherapy for severe tuberculosis meningitis.
Donald PR, Schoeman JF, O'Kennedy A. Donald PR, et al. Am J Dis Child. 1987 Jul;141(7):741-3. doi: 10.1001/archpedi.1987.04460070043019. Am J Dis Child. 1987. PMID: 2884866
The remaining 23 children were observed for a mean period of only four weeks, and 18 (75%) had at least one abnormal liver function test result....
The remaining 23 children were observed for a mean period of only four weeks, and 18 (75%) had at least one abnormal liver function t …
35 results